Factor X Activating Enzyme from Russell's Viper Venom: Isolation and Characterization
Overview
Authors
Affiliations
The protease from Russell's viper venom that activates factor X (Stuart factor), factor IX (Christmas factor), and protein C was purified by gel filtration on Sephadex G-150 and QAE-Sephadex A-50 column chromatography. The purified enzyme migrated as a single band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis with an apparent molecular weight of 79 000. A minimal molecular weight of 78 500 +/- 800 was determined by sedimentation equilibrium in the presence of 6 M guanidine hydrochloride. Upon reduction with 2-mercaptoethanol, a heavy chain (mol wt 59 000) and a light chain were observed. The light chain migrated as a single band (mol wt 19 000) in 7.5% polyacrylamide-sodium dodecyl sulfate gels but appeared as a doublet (mol wt 18 000 and 20 000) in 10% polyacrylamide-sodium dodecyl sulfate gels. The amino-terminal end of the heavy chain was heterogeneous and contained isoleucine, valine and serine. The amino-terminal sequence of the light chain was Val-Leu-Asp. The factor X activator contained 13% carbohydrate including 6.0% hexose, 1.7% N-acetyleneuraminic acid, and 5.3% galactosamine. Most of the carbohydrate was found to be present in the heavy chain, although some was also observed in both forms of the light chain. The factor X activator had no esterase activity toward benzoyl-Phe-Val-Arg-p-nitroanilide or benzoylarginine ethyl ester and was not inhibited by 0.05 M diisopropyl phosphorofluoridate. These data indicate that factor X activator from Russell's viper venom is a highly specific protease composed of one heavy chain and one light chain, and these chains are held together by a disulfide bond(s).
Kempson K, Chowdhury A, Violette A, Fourmy R, Soria R, Fry B Toxins (Basel). 2024; 16(12.
PMID: 39728778 PMC: 11728708. DOI: 10.3390/toxins16120520.
Feng Y, Ma J, Tang L, Lin W, Tao Y, Cheng Z Genes (Basel). 2021; 12(10).
PMID: 34680916 PMC: 8535979. DOI: 10.3390/genes12101521.
Kini R, Koh C Toxins (Basel). 2016; 8(10).
PMID: 27690102 PMC: 5086644. DOI: 10.3390/toxins8100284.
A rapid pro-hemostatic approach to overcome direct oral anticoagulants.
Thalji N, Ivanciu L, Davidson R, Gimotty P, Krishnaswamy S, Camire R Nat Med. 2016; 22(8):924-32.
PMID: 27455511 DOI: 10.1038/nm.4149.
Hemostatic agents of broad applicability produced by selective tuning of factor Xa zymogenicity.
Ivanciu L, Camire R Blood. 2015; 126(1):94-102.
PMID: 25896653 PMC: 4492200. DOI: 10.1182/blood-2015-03-634329.